ERG and cancer: Strong ANO7 staining was less prevalent in cancers harboring TMPRSS2:ERG rearrangements (24%) and ERG expression (25%) than in cancer lacking ERG fusions (43%) or ERG expression (45%, P < 0.0001 each, Supplementary Figure S1).